European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES
ABOUT
The EHS Task Force has been set up due to the considerable success with the launching of the annual European Health Summit. This platform has been designed to drive policy in the domain of health, aside from organising high-level annual events.
The aim is not only to create a larger healthcare network and provide visibility, but also to be able to steer the process of policy making at the European level and strengthen the link between public and private partnership through the involvement of cross-sectorial stakeholders.
The aim is not only to create a larger healthcare network and provide visibility, but also to be able to steer the process of policy making at the European level and strengthen the link between public and private partnership through the involvement of cross-sectorial stakeholders.
CONFIRMED SPEAKERS
Sandra Gallina
Director General DG SANTE
István Ujhelyi
Member of the European Parliament
Sirpa Pietikäinen
Member of the European Parliament
Margarita de la Pisa
Member of the European Parliament
Antonella Cardone
CEO Cancer Patients Europe
Martine Pergent
President of International Patient Organization for Primary Immunodeficiencies (IPOPI)
Panos Kanavos
Associate Professor of International Health Policy at London School of Economics (LSE)
Elizabeth Kuiper
Associate Director at European Policy Centre
Patrick Stockebrandt
Head of Division at the Centre for European Policy
Heike Prinz
Head of Commercial Operations EMEA for the Pharmaceuticals Division and ExCo Member at Bayer AG
Elisabetta Zanon
Director of EU Public Affairs and Advocacy of the Alliance for Regenerative Medicine (ARM)
Laura Campo
Executive Director International Corporate Affairs, Alzheimer’s disease, Eli Lilly and Company
Enrico Lugli
Group Leader and Head of Facility at Humanitas Research Hospital
Ruediger Gatermann
Senior Director EU Policy Strategy at CSL Behring
Mariam Zaidi
Euronews, Euractiv, CNBC Presenter
Sarah-Taïssir Bencharif
EU Health Journalist
TASK FORCE MEETINGS
10 MAY 2023
Closed meeting
A PHARMA STRATEGY FOR RARE AND NON-COMMUNICABLE DISEASES?
The revision of the EU’s Pharma Strategy offers a once in a generation opportunity to highlight to current shortcomings and opportunities in EU health policy when it comes to rare and non-communicable diseases (cardiovascular disease, diabetes etc.). Given the nature of public-private partnerships in the healthcare landscape, listening to the voices of industry is a key factor when it comes to fostering innovation and translating this into improved patient outcomes.
MAY 2023
Closed meeting
ARTIFICIAL INTELLIGENCE AND THE EUROPEAN HEALTH DATA SPACE
AI offers unprecedented opportunities for healthcare, such as reduced costs, increased automation and rapid data processing. On the other hand, questions of data privacy, bias and vulnerabilities may also increase health inequalities. As the EU moves towards the implementation of the EHDS, engaging with stakeholders and ensuring that opportunities can be properly harnessed will be essential for its success.
SEPTEMBER 2023
Closed meeting
AN INNOVATIVE AND COMPETITIVE HEALTHCARE INDUSTRIAL POLICY FOR EUROPE
As the EU struggles to attract and maintain R&D and investments in the healthcare sector coupled with strategic vulnerabilities in supply chains, the need to develop home-grown and innovative treatments has never been more apparent. Reducing IP and regulatory hurdles in the EU, along with incentivizing investment, infrastructure and skills will be vital to cultivate a competitive healthcare ecosystem.
8 JUNE 2023
European health task force summit
Have a question? Contact our team!
